Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A landscape of the genetic and cellular heterogeneity in Alzheimer disease

View ORCID ProfileLogan Brase, View ORCID ProfileShih-Feng You, View ORCID ProfileJorge del Aguila, View ORCID ProfileYaoyi Dai, View ORCID ProfileBrenna C Novotny, View ORCID ProfileCarolina Soriano-Tarraga, View ORCID ProfileTaitea Dykstra, Maria Victoria Fernandez, View ORCID ProfileJohn P Budde, Kristy Bergmann, View ORCID ProfileJohn C Morris, View ORCID ProfileRandall J Bateman, Richard J Perrin, View ORCID ProfileEric McDade, Chengjie Xiong, View ORCID ProfileAlison Goate, View ORCID ProfileMartin Farlow, View ORCID ProfileJasmeer P. Chhatwal, View ORCID ProfilePeter Schofield, Helena Chui, Dominantly Inherited Alzheimer Network (DIAN), Greg T Sutherland, View ORCID ProfileJonathan Kipnis, View ORCID ProfileCeleste M Karch, View ORCID ProfileBruno A Benitez, View ORCID ProfileCarlos Cruchaga, View ORCID ProfileOscar Harari
doi: https://doi.org/10.1101/2021.11.30.21267072
Logan Brase
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Logan Brase
Shih-Feng You
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shih-Feng You
Jorge del Aguila
12Merck & Co., Inc., Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jorge del Aguila
Yaoyi Dai
11Baylor College of Medicine, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yaoyi Dai
Brenna C Novotny
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brenna C Novotny
Carolina Soriano-Tarraga
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolina Soriano-Tarraga
Taitea Dykstra
6Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
7Center for Brain Immunology and Glia (BIG), Washington University in St. Louis, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Taitea Dykstra
Maria Victoria Fernandez
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Budde
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John P Budde
Kristy Bergmann
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C Morris
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
4Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
5Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John C Morris
Randall J Bateman
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
4Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
5Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Randall J Bateman
Richard J Perrin
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
4Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
5Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
6Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric McDade
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric McDade
Chengjie Xiong
4Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
13Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Goate
10Dominantly Inherited Alzheimer Network (DIAN)
14Ronald M. Loeb Center for Alzheimer’s Disease, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alison Goate
Martin Farlow
10Dominantly Inherited Alzheimer Network (DIAN)
15Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Farlow
Jasmeer P. Chhatwal
10Dominantly Inherited Alzheimer Network (DIAN)
16Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jasmeer P. Chhatwal
Peter Schofield
10Dominantly Inherited Alzheimer Network (DIAN)
17Neuroscience Research Australia, Sydney, NSW, Australia
18School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Schofield
Helena Chui
10Dominantly Inherited Alzheimer Network (DIAN)
19Alzheimer’s Disease Research Center, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA
20Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg T Sutherland
9School of Medical Sciences and Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Kipnis
6Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
7Center for Brain Immunology and Glia (BIG), Washington University in St. Louis, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Kipnis
Celeste M Karch
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Celeste M Karch
Bruno A Benitez
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno A Benitez
Carlos Cruchaga
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
10Dominantly Inherited Alzheimer Network (DIAN)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Cruchaga
Oscar Harari
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
2Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics, Department of Psychiatry Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oscar Harari
  • For correspondence: harario@wustl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Alzheimer disease (AD) has substantial genetic, molecular, and cellular heterogeneity associated with its etiology. Much of our current understanding of the main AD molecular events associated with the amyloid hypothesis (APP, PSEN1 and PSEN2) and neuroimmune modulation (TREM2 and MS4A) is based on genetic studies including GWAS. However, the functional genes, downstream transcriptional ramifications, and the cell-type-specific effects of many GWAS loci remain poorly understood. Understanding these effects can point us to the cellular processes involved in AD and uncover potential therapeutic targets.

Methods We applied a genetic-based approach to our sample selection; our cohort included carriers of AD pathogenic mutations (APP, PSEN1), risk variants in TREM2, and the resilience variant (rs1582763) in the MS4A cluster associated with cerebrospinal fluid (CSF) soluble TREM2 levels. We performed single-nucleus RNA-sequencing (snRNA-seq) of 1,102,459 nuclei from the human parietal cortex of these carriers. Following initial unbiased clustering and cell-type annotation, we performed deep subclustering analysis per cell type to identify unique cellular transcriptional states associated with these genetic variants. We identified differentially expressed genes between cell states and genetic variant carriers/controls, and performed differential cell proportion analyses to determine key differences among these carriers. We analyzed sequencing data from human dorsolateral prefrontal cortex and mouse models to replicate the enrichment of unique cell states in genetic variant carriers. Finally, we leveraged these cell-state differential expression results to link genes in AD GWAS loci to their functional cell types.

Findings We identified cell-specific expression states influenced by AD genetic factors for neurons and glia. Autosomal dominant AD (ADAD) brains exhibited unique transcriptional states in all cell types. TREM2 variant carrier brains were also enriched for specific microglia and oligodendrocyte subpopulations. Carriers of the resilience MS4A variant were enriched for an altered activated-microglia expression state. We mapped AD GWAS genes to their potential functional cell types, and some, including PLCG2 and SORL1, were expressed in a broader range of brain cell types than previously reported.

Interpretation AD pathogenic, risk, or resilience variants are sufficient to alter the transcriptional and cellular landscape of human brains. Overall, our results suggest that the genetic architecture contributes to the cortical cellular heterogeneity associated with disease status, which is a critical factor to consider when designing drug trials and selecting the treatment program for AD patients.

Our findings suggest that integrating genetic and single-cell molecular data facilitates our understanding of the heterogeneity of pathways, biological processes and cell types modulated by genetic risk factors for AD.

Funding US National Institutes of Health, Hope Center, Archer foundation, Alzheimer Association, CZI.

Competing Interest Statement

Carlos Cruchaga (CC) receives research support from: Biogen, EISAI, Alector and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of Vivid genetics, Halia Therapeutics and ADx Healthcare.

Funding Statement

This work was possible thanks to the following governmental grants from the National institute of Health: NIA R01AG057777 (OH), R56AG067764 (OH) P30AG066444 (JCM), P01AGO26276 (JCM), U19AG032438 (RJB), R01AG044546 (CC), P01AG003991 (JCM), RF1AG053303 (CC), RF1AG058501 (CC), U01AG058922 (CC), NINDS R01NS118146 (BAB), RFNS110809 (CMK), R01AG062734 (CMK), U01AD072464 (OH, CMK), the BrightFocus Foundation (CMK), and the Chan Zuckerberg Initiative (CZI). O.H. is an Archer Foundation Research Scientist. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Human Research Protective Office of Washington University in St. Louis gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The single nucleus data from the Knight ADRC is publicly available by request from the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) with accession number NG00108 (https://www.niagads.org/datasets/ng00108). To access the data from the DIAN brain bank, special request must be made using this URL: https://dian.wustl.edu/our-research/for-investigators/. The 5xFAD mouse microglia data are located in the Gene Expression Omnibus (GEO database) under the accession number GSE141917 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141917). The ROSMAP single nucleus RNA sequencing data is available at Synapse under Synapse ID syn21125841 (https://www.synapse.org/#!Synapse:syn21125841/wiki/597278). Custom code used to analyze the snRNA-seq data and datasets generated and/or analyzed in the current study are available from the corresponding authors upon request.

https://www.niagads.org/datasets/ng00108

https://dian.wustl.edu/our-research/for-investigators/

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141917

https://www.synapse.org/%23!Synapse:syn21125841/wiki/597278

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 02, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A landscape of the genetic and cellular heterogeneity in Alzheimer disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A landscape of the genetic and cellular heterogeneity in Alzheimer disease
Logan Brase, Shih-Feng You, Jorge del Aguila, Yaoyi Dai, Brenna C Novotny, Carolina Soriano-Tarraga, Taitea Dykstra, Maria Victoria Fernandez, John P Budde, Kristy Bergmann, John C Morris, Randall J Bateman, Richard J Perrin, Eric McDade, Chengjie Xiong, Alison Goate, Martin Farlow, Jasmeer P. Chhatwal, Peter Schofield, Helena Chui, Dominantly Inherited Alzheimer Network (DIAN), Greg T Sutherland, Jonathan Kipnis, Celeste M Karch, Bruno A Benitez, Carlos Cruchaga, Oscar Harari
medRxiv 2021.11.30.21267072; doi: https://doi.org/10.1101/2021.11.30.21267072
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A landscape of the genetic and cellular heterogeneity in Alzheimer disease
Logan Brase, Shih-Feng You, Jorge del Aguila, Yaoyi Dai, Brenna C Novotny, Carolina Soriano-Tarraga, Taitea Dykstra, Maria Victoria Fernandez, John P Budde, Kristy Bergmann, John C Morris, Randall J Bateman, Richard J Perrin, Eric McDade, Chengjie Xiong, Alison Goate, Martin Farlow, Jasmeer P. Chhatwal, Peter Schofield, Helena Chui, Dominantly Inherited Alzheimer Network (DIAN), Greg T Sutherland, Jonathan Kipnis, Celeste M Karch, Bruno A Benitez, Carlos Cruchaga, Oscar Harari
medRxiv 2021.11.30.21267072; doi: https://doi.org/10.1101/2021.11.30.21267072

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1950)
  • Dentistry and Oral Medicine (253)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11115)
  • Forensic Medicine (8)
  • Gastroenterology (628)
  • Genetic and Genomic Medicine (3189)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2046)
  • Health Policy (864)
  • Health Systems and Quality Improvement (783)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12733)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2996)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1559)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2793)
  • Public and Global Health (5605)
  • Radiology and Imaging (1096)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (763)
  • Rheumatology (340)
  • Sexual and Reproductive Health (312)
  • Sports Medicine (289)
  • Surgery (346)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)